4.2 Editorial Material

Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT)

Journal

STEM CELL RESEARCH
Volume 16, Issue 1, Pages 70-74

Publisher

ELSEVIER
DOI: 10.1016/j.scr.2015.12.008

Keywords

-

Funding

  1. Danish National Advanced Technology Foundation [047-2011-1]
  2. European Union 7th Framework Program [PIAP-GA-2012-324451-STEMMAD]
  3. Novo Nordisk Fonden [NNF11OC1014514] Funding Source: researchfish

Ask authors/readers for more resources

Skin fibroblasts were obtained from a 57-year-old woman diagnosed with frontotemporal dementia. The disease is caused by a P301L mutation in microtubule-associated protein tau (MAPT). Induced pluripotent stem cells (iPSCs) were established by electroporation with episomal plasmids containing hOCT4, hSOX2, hKLF2, hL-MYC, hLIN-28 and shP53. iPSCs were free of genomically integrated reprogramming genes, contained the expected c.902C>T substitution in exon 10 of the MAPT gene, expressed the expected pluripotency markers, displayed in vitro differentiation potential to the three germ layers and had normal karyotype. The iPSC line may be useful for studying hereditary frontotemporal dementia and TAU pathology in vitro. (C) 2015 Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available